We are live on ! Find out more
HCA

Harbor Capital Advisors Portfolio holdings

AUM $1.47B
1-Year Est. Return 42.58%
This Fund
S&P 500
This Quarter Est. Return
-26.69%
1 Year Est. Return
+42.58%
3 Year Est. Return
+118.91%
5 Year Est. Return
10 Year Est. Return
AUM
$131M
AUM Growth
-$80.7M
Cap. Flow
-$21.4M
Cap. Flow %
-16.31%
Top 10 Hldgs %
31.3%
Holding
169
New
9
Increased
78
Reduced
72
Closed
9

Top Buys

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$3.74M
2
NET icon
Cloudflare
NET
+$1.86M
3
MELI icon
Mercado Libre
MELI
+$1.64M
4
AVLR
Avalara, Inc.
AVLR
+$1.38M
5
WOLF icon
Wolfspeed
WOLF
+$1.36M

Sector Composition

Rank Sector Weight
1 Technology 50.67%
2 Healthcare 20.24%
3 Consumer Discretionary 14.97%
4 Communication Services 9.75%
5 Financials 1.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSTR icon
76
Strategy Inc
MSTR
$37.9B
$300K 0.23%
18,240
-38,510
-68% -$1.11M
FATE icon
77
Fate Therapeutics
FATE
$318M
$284K 0.22%
11,452
-1,256
-10% -$34.7K
NVTA
78
DELISTED
Invitae Corporation
NVTA
$254K 0.19%
+103,918
New +$460K
KYMR icon
79
Kymera Therapeutics
KYMR
$9.11B
$241K 0.18%
12,265
-1,730
-12% -$40.4K
COIN icon
80
Coinbase
COIN
$39.2B
$229K 0.17%
4,863
-9,382
-66% -$893K
UTHR icon
81
United Therapeutics
UTHR
$22.1B
$198K 0.15%
840
-2
-0.2% -$407
DNTH icon
82
Dianthus Therapeutics
DNTH
$6.07B
$191K 0.15%
9,957
+482
+5% +$11.9K
TCRR
83
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$187K 0.14%
64,341
-3,222
-5% -$7.95K
CCCC icon
84
C4 Therapeutics
CCCC
$427M
$183K 0.14%
24,314
+2,446
+11% +$21.5K
ALNY icon
85
Alnylam Pharmaceuticals
ALNY
$29.6B
$176K 0.13%
1,208
+108
+10% +$15.3K
VMW
86
DELISTED
VMware, Inc
VMW
$175K 0.13%
1,534
+190
+14% +$21.6K
RARE icon
87
Ultragenyx Pharmaceutical
RARE
$2.66B
$174K 0.13%
2,918
+592
+25% +$36.4K
DT icon
88
Dynatrace
DT
$14.4B
$171K 0.13%
4,346
+594
+16% +$23.6K
PLTR icon
89
Palantir
PLTR
$420B
$170K 0.13%
18,688
+7,282
+64% +$72K
PLUG icon
90
Plug Power
PLUG
$3.08B
$167K 0.13%
10,094
+3,760
+59% +$74.6K
NEWR
91
DELISTED
New Relic, Inc.
NEWR
$167K 0.13%
3,346
+1,022
+44% +$56.7K
NTRA icon
92
Natera
NTRA
$45.1B
$166K 0.13%
4,674
+2,280
+95% +$84.4K
PFE icon
93
Pfizer
PFE
$152B
$163K 0.12%
3,100
-302
-9% -$15.4K
JAMF
94
DELISTED
Jamf
JAMF
$162K 0.12%
6,542
+1,808
+38% +$50.7K
FWONK icon
95
Liberty Media Series C
FWONK
$25.7B
$161K 0.12%
2,625
-190
-7% -$11.6K
INTU icon
96
Intuit
INTU
$92B
$160K 0.12%
416
+84
+25% +$34.8K
BIIB icon
97
Biogen
BIIB
$30.1B
$159K 0.12%
780
-6
-0.8% -$1.23K
MRK icon
98
Merck
MRK
$322B
$158K 0.12%
1,728
-462
-21% -$41K
DBX icon
99
Dropbox
DBX
$7.41B
$157K 0.12%
7,460
+726
+11% +$15.7K
PCTY icon
100
Paylocity
PCTY
$7.7B
$157K 0.12%
898
+96
+12% +$17.5K

Similar funds

Harbor Capital Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Harbor Capital Advisors held 169 positions worth $131M, down 38% from $212M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Harbor Capital Advisors withdrew a net $21.4M in Q2 2022, closing 9 positions and reducing 72 holdings. Its most notable exit was SailPoint Technologies Holdings, Inc. Common Stock, an estimated $3.73M position sold in full.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 47% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Harbor Capital Advisors opened a new position in Wolfspeed worth $1.04M.

  • Harbor Capital Advisors's largest Q2 2022 buy was Wolfspeed: 16,341 shares worth $1.04M.
  • Harbor Capital Advisors added most to Okta in Q2 2022, an estimated $3.74M increase.
  • Harbor Capital Advisors's biggest Q2 2022 reduction was Amazon, cutting an estimated $4.21M.
  • Harbor Capital Advisors fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q2 2022, selling an estimated $3.73M.
  • Harbor Capital Advisors's ten largest holdings make up 31% of its $131M portfolio in Q2 2022.
  • Harbor Capital Advisors opened 9 new positions and closed 9 in Q2 2022.
  • Harbor Capital Advisors's portfolio value fell 38% quarter-over-quarter to $131M.

Based on Harbor Capital Advisors's 13F filing for Q2 2022, filed 26 Jul 2022.